FRIEDMAN PAUL A sold MDGL
August 11, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 300 shares of Madrigal Pharmaceuticals, Inc. at $351.04 per share, a transaction worth $105.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$351.04
Total value
$105.3K
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after187,164
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.24, inclusive.